Ilyang Pharmaceutical Co.,Ltd Tangible Net Worth Ratio
Ilyang Pharmaceutical Co.,Ltd tangible net worth ratio. Ilyang Pharmaceutical Co.,Ltd (007575) has a Tangible Net Worth Ratio of 89.9% as of June 2026. This metric is calculated by deducting intangible assets (₩26.07 Billion) from net assets (₩256.94 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Ilyang Pharmaceutical Co.,Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Ilyang Pharmaceutical Co.,Ltd (2014–2025)
Tangible net worth ratio of Ilyang Pharmaceutical Co.,Ltd from 2014 to 2025. This chart shows how Ilyang Pharmaceutical Co.,Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 89.9%, reflecting net assets of ₩256.94 Billion with intangible assets of ₩26.07 Billion KRW. See working capital to net assets of Ilyang Pharmaceutical Co.,Ltd to evaluate short-term liquidity relative to the company's equity base.
Ilyang Pharmaceutical Co.,Ltd Tangible Net Worth Ratio by Year (2014–2025)
Ilyang Pharmaceutical Co.,Ltd tangible net worth ratio by year from 2014 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Ilyang Pharmaceutical Co.,Ltd from 2014 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Ilyang Pharmaceutical Co.,Ltd.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.3% | ₩241.41 Billion | ₩25.75 Billion | ₩457.33 Billion | ▼ -0.1 pp |
| 2024 | 89.4% | ₩239.53 Billion | ₩25.34 Billion | ₩431.03 Billion | ▲ +3.3 pp |
| 2023 | 86.1% | ₩196.41 Billion | ₩27.26 Billion | ₩356.66 Billion | ▲ +11.8 pp |
| 2022 | 74.3% | ₩291.85 Billion | ₩74.90 Billion | ₩498.19 Billion | ▼ -1.7 pp |
| 2021 | 76.0% | ₩271.76 Billion | ₩65.16 Billion | ₩494.27 Billion | ▲ +0.3 pp |
| 2020 | 75.7% | ₩244.92 Billion | ₩59.40 Billion | ₩439.12 Billion | ▼ -0.9 pp |
| 2019 | 76.7% | ₩222.74 Billion | ₩52.00 Billion | ₩437.46 Billion | ▲ +0.8 pp |
| 2018 | 75.8% | ₩209.88 Billion | ₩50.72 Billion | ₩432.25 Billion | ▼ -3.2 pp |
| 2017 | 79.1% | ₩210.98 Billion | ₩44.18 Billion | ₩436.37 Billion | ▲ +3.5 pp |
| 2016 | 75.6% | ₩217.35 Billion | ₩53.13 Billion | ₩431.26 Billion | ▼ -21.9 pp |
| 2015 | 97.4% | ₩211.00 Billion | ₩5.41 Billion | ₩431.63 Billion | ▲ +0.3 pp |
| 2014 | 97.2% | ₩183.46 Billion | ₩5.22 Billion | ₩430.83 Billion | — |